Stocks and Investing
Stocks and Investing
Tue, September 6, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, September 5, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, September 2, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (VRTX) at Hold and Held Target at $276 on, Sep 2nd, 2022
Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $276 on, Sep 2nd, 2022.
Brian has made no other calls on VRTX in the last 4 months.
There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 5 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Do Kim of "Piper Sandler" Maintained at Hold with Increased Target to $288 on, Wednesday, August 17th, 2022
- Paul Matteis of "Stifel" Maintained at Hold and Held Target at $263 on, Wednesday, August 10th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $253 on, Monday, August 8th, 2022
- Brian Skorney of "Baird" Maintained at Hold and Held Target at $250 on, Friday, August 5th, 2022
- David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $265 on, Monday, May 23rd, 2022
These are the ratings of the 8 analyists that currently disagree with Brian
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $307 on, Friday, August 5th, 2022
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Friday, August 5th, 2022
- Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $365 on, Wednesday, July 13th, 2022
- Phil Nadeau of "Cowen & Co." Maintained at Buy with Increased Target to $310 on, Monday, June 13th, 2022
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $280 on, Monday, June 13th, 2022
- Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $325 on, Wednesday, June 1st, 2022
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $278 on, Tuesday, May 24th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $305 on, Friday, May 6th, 2022
Contributing Sources